Dear Authors,
If you believe that your paper was mistakenly rejected by other leading journals and you do not agree with final decision, the editors of Reports of Practical Oncology and Radiotherapy offer new fast track review. You may submit your manuscript to Reports of Practical Oncology and Radiotherapy together with all prior peer-reviews obtained from the other journal and your rebuttal letter. We guarantee review based decision within 72 hours from the time we will receive your manuscript.

Fast track submission process: Please submit the manuscript with all reviews and rebuttal letter by email to Dr. Michal Masternak ( for fast review processing. To assure immediate attention the email title must to include: RPOR-fast track- Last Name First Name (of corresponding author).

Volume 6, Number 1, 2001


Rola systemu Varis i Vision w nowoczesnej radioterapii.

Naczk E.
p. 27-27

Soma Vision - new possibilities in computer treatment planning

Smolińska B, Bereza I, Eberhardt B.
p. 27-27

Weryfikacja obliczonych przez system planowania leczenia CADPLAN v.3.1 dawek w maksimum RD (reference dose).

Laskosz I, Janiszewska M, Nowakowski G.
p. 27-28

Optimization of dose distribution with individual beam compensators

Kuszewski T, Wesołowski J, Kukołowicz P.
p. 28-28

Analysis of differences between doses calculated and measured in-vivo during irradiation with mantle fields

Litoborski M.
p. 28-29

The technique of Total Body Irradiation applied in the St. Leszczyński Memorial Hospital in Katowice

Kawa - Iwanicka A, Dybek M, Iwanicki T, Łobodziec W, Radkowski A.
p. 29-29

IMRT - new standards in treatment planning.

Grządziel A, Ślosarek K, Rutkowski R, Rembielak A.
p. 29-30

Evaluation of a new system for in-vivo dosimetry based on mosfet detectors

Kukołowicz P, Buliński K, Lis K, Miedzińska J.
p. 30-30

Comparison between conventional simulator planning and conformal 3-D planning for cervical cancer teletherapy

Bratos K, Roszak A, Cikowska-Woźniak E, Piotrowski T.
p. 30-31

The comparison between the three - field and four-field techniques of planning of radiotherapy in prostate cancer.

Milecki P, Piotrowski T, Dymnicka M, Malicki J, Stryczyńska G
p. 31-31

The analysis of doses in the tumour and in critical tissues in the brachytherapy of malignant melanoma localised in eyes.

Kierzkowski J, Malicki J, Roszak A.
p. 31-32

The evaluation of clinical, histological and molecular predictive and grognostic factors in patients with advanced squamous cell cancer of the larynx, meso- and hypopharynx, floor of mouth irradiated after induction chemotherapy.

Małecki K.
p. 32-32

Immunogenetherapy combined with brain metastases irradiation in melanoma patients

Nawrocki S, Karczewska A, Milecki P, Iżycki D, Stryczyńska G, Mackiewicz A.
p. 32-32

Search for improvement of the therapeutic ratio in radiotherapy for non-small cell lung cancer (NSCLC)

Kępka L, Fijuth J, Żółciak A, Blatkiewicz D, Ciarcińska A, Bulski W.
p. 33-33

Radiation survival and colony size of human epidermal keratinocytes in the presence of keratinocyte growth factor (rhKGF)

Slonina D, Dörr W.
p. 33-34

Tolerance of radiotherapy (3D-CRT) and androgen ablation for patients with prostate cancer

Milecki P, Stryczyńska G, Stachowski T, Kwias Z, Matecka-Nowak M.
p. 34-34

Gene therapy of cancer

Mackiewicz A.
p. 34-34

Do we game any benefit from accelerated in radiotherapy for head and neck tumor cancer - weekend's mystery?

Maciejewski B, Withers HR, Tarnawski R.
p. 34-35

Does in vivo dosimetry improve quality of radiotherapy: evaluation of 1000 patient's checks.

Malicki J, Kierzkowski J, Kosicka G, Dymnicka M, Stryczyńska G.
p. 35-35

Setting the pace for strengthening radiotherapy in Europe: the ESTRO esquire project

Heeren G, Barrett A, Baumann M, Dutreix A, Huyskens D, Lartgau E, Mijnheer B, Venselaar J, Svensson H.
p. 35-36

The structure and activity of international organisations for medical physics and biomedical engineering

Chomicki OA.
p. 36-37

Current status of systematic radiopharmaceuticals for the treatment of painful metastatic bone disease

Pirich C.
p. 37-37

Principles of radioiodine treatment (131 I) for patients with differentiated thyroid carcinomas

Sowiński J.
p. 37-37

Validation of conformal radiotherapy treatment planning systems using an antropomorphic phantom and thermoluminescence dosimetry

Waligórski MPR, Lesiak J, Byrski E, Rozwadowska-Bogusz B, Barańczyk R, Góra E, Bilski P, Olko P.
p. 38-38

Assessment of the accuracy of radiotherapy by digital superposition of portal and reference images

Gut P, Kukołowicz P, Chmielewski L, Dąbrowski A.
p. 38-39

Chromosomal damage and survival of keratinocytes and fibroblasts after irradiation with 200 KV or 25 KV X-rays

Slonina D, Brankovic K, Panteleeva A, Dorr W.
p. 39-39

Time factor in postoperative radiotherapy for squamous cell head and neck cancer; a multivariate locoregional control analysis in 942 patients

Suwiński R, Sowa A, Rutkowski T, Maciejewski B.
p. 40-40

Comparison of doses measured by thermoluminescent and semiconductor detectors during total body irradiation at Cobalt-60 and 15 MeV linear accelerator

Nowak A, Malicki J, Wachowiak J, Kosicka G, Stryczyńska G.
p. 40-40

Results of postoperative radiotherapy in low-grade gliomas

Kępka L, Fijuth J, Leszczyk C, Dyttus-Cebulok K, Żółciak A.
p. 41-41

Progress in palliative radiotherapy

Skołyszewski J.
p. 41-42

Endovascular brachytherapy

Pötter R.
p. 42-42

Quality assurance for new techniques of brachytherapy

Marinello G, Gres B.
p. 42-42

Last results and lessons of the Estro European network on quality assurance in radiotherapy

Ferreira IH, Dutreix A, Bridier A, Marre D, Chavaudra J, Svensson H.
p. 42-42

A multicenter randomized study of two regimens in paliative radiotherapy of bone metastases

Badzio A, Jereczek-Fossa B, Senkus-Konefka E, Adamska K, Fajndt I, Tesmer-Laskowska I, Janus-Kowalska E, Jassem J.
p. 43-43

How often medical literature may be a source of incorrect clinical decision?

Bujko K, Nowacki MP, Michalski W.
p. 43-43

A prospective, randomized study to compare the value of two fractionation schemes of palliative radiotherapy for inoperable non-small cell lung cancer

Senkus-Konefka E, Jassem J, Bednaruk-Mlynski E, Dziadziuszko R, Kubrak J, Lewandowska A, Malachowski K, Wierzchowski M, Rzepecki J, Chyczewska E, Matecka-Nowak M.
p. 43-44

Multicenter, randomized study assessing the impact of amifostine on normal tissue radiation tolerance during head and neck cancer radiotherapy

Senkus-Konefka E, Jassem J, Bednaruk-Mlynski E, Badzio A, Madrzak J, Matuszewska K, Kawecki A, Pietrusinska E, Kedzierawski P, Rucinska M.
p. 44-44

The own experience in monitoring the late radiation reaction of criticual tissues in head and neck region

Goleń M, Składowski K, Wygoda A, Przeorek W, Pilecki B, Syguła M, Kołosza Z.
p. 44-45

Pulsed dose rate brachytherapy - describing of a method and a review of clinical application

Skowronek J, Piotrowski T, Zwierzchowski G.
p. 45-45

Advanced non-small cell lung cancer (NSCLC) - hyper-fractionated conventional accelerated radiotherapy (RAHIP) and accelerated conformal radiotherapy with concurrent boost (RT-BOOST)

Kępka L, Fijuth J, Żółciak A, Blatkiewicz D, Ciarcińska A.
p. 45-46

Estimation of dose distrubution according to dose volume histograms (DVH) in conformal radiotherapy

Ślosarek K, Składowski K.
p. 46-46

Results of daily control of patients setup treated on Holycross Cancer Centre in Kielce between 1 April 2000 and 31 March 2001

Dąbrowski A, Kukołowicz PF.
p. 46-47

Neoadjuvant radiotherapy of epidermiod lung carcinoma patients under short term hypoxia condition

Nazarenko A, Goldobenko GV, Tkachev SI, Ivanov SM.
p. 47-47

Radiation therapy in the treatment of partially resected low-grade cere-bellar astrocytomas in adult patients

Pluta E, Gliński B, Nowak-Sadzikowska J.
p. 47-47

Impact of HB level during postoperative radiotherapy of patients with larynx cancer

Milecki P, Nawrocki S, Stryczyńska G, Kruk-Zagajewska A, Fundowicz D.
p. 47-48

Stereotactic mammotome breast biopsy - analysis of results

Murawa P, Fedorowicz T, Kobylarek R, Nowakowski W, Wasiewicz J.
p. 48-48

Allogeneic bone marrow transplantation in children with acute lymphoblastic leukemia in first and second complete remission conditioned with fractionated total body irradiation and etoposide or cyclophosphamide

Wachowiak J, Malicki J, Boruczkowski D, Stryczyńska G, Kosicka G, Leda M, Pieczonka A.
p. 48-49

Combined chemotherapy and radiation in locally advanced NSCLC

Jassem J.
p. 49-49

Adjuvant treatment to surgery: is it still a place for radio - or chemotherapy?

Van Houtte P.
p. 49-50

The importance of modifying hypoxia in radiotherapy

Overgaard J.
p. 50-50

Biological concepts of breast cancer: implications for therapy

Tubiana M, Koscielny S.
p. 50-50

Development of network of cancer family syndrome registries in Eastern Europe

Lubinski J.
p. 51-51

Postmastectomy radiotherapy (PMRT)

Korzeniowski S.
p. 51-51

Lymphatic mapping and sentinel lymph node biopsy in breast cancer patients in clinical stage T1-T2 NO MO

Murawa P, Mańczak M, Wasiewicz J, Gracz A, Bręborowicz D, Malicki J.
p. 52-52

How often should we obtain complete blood counts (CBC's) from patients receiving radical radiation therapy?

Dziadziuszko R, Sosińska-Mielcarek K, Szutowicz-Zielinska E, Jassem J.
p. 52-52

The role of external irradiation in postoperative treatment of soft tissue sarcomas - last decade of Gliwice experience

Sąsiadek W, Pilecki B, Syguła M, Goleń M, Przeorek W, Mucha A, Wygoda A, Składowski K.
p. 53-53

Physical and dosimetric aspects of quality assurance in stereotactic radiotherapy

Rostkowska J, Kania M, Bulski W, Kawczyńska M, Fijuth J, Wysocka A.
p. 53-53

Influence of total time of surgery and postoperative radiotherapy on the outcome patients with advanced laryngeal carcinoma

Milecki P, Stryczyńska G, Kruk-Zagajewska A, Nawrocki S, Adamiak E.
p. 54-54

Verification of the 3-D dose calculation algorithm during total skin electron irradiation with the rotary-dual field technique

Piotrowski T, Malicki J, Pracz J.
p. 54-54

Factors determining local control in patients (PTS) with locally advanced breast cancer (Labc) managed with radiotherapy (Rt) as the primary locoregional treatment

Rogowski W, Dziadziuszko R, Madrzak J, Welnicka-Jaskiewicz M, Barrett-Lee P, Jassem J.
p. 55-55

The outcomes of the conventionally fractionated radio-therapy in the prospective and retrospective studies. Is the meaning of conventionality the same?

Hliniak A, Michalski W, Szutkowski Z, Kraszewska E, Jarząbski A.
p. 55-56

The radiotherapy of IMRT

Bentzen SM.
p. 56-56

Stereotactic radiotherapy for primary and recurrent brain tumors. A new method for improvement of the treatment results?

Fijuth J.
p. 56-56

State of Monte Carlo calculations in radiation treatment planning

Rosenow U.
p. 56-57

Physical and clinical dosimetry by means of Monte Carlo using a process distribution tool

Sanchez-Doblado F, Leal A, Perucha M, Rincon M, Nunez L, Rosello J, Gonzalez A, Carrasco E, Medrano JC, Sanchez-Calzado JA, Errazquin L.
p. 57-57

Late effects of CNS prophylactic irradiation in child-hood due to LLA using magnetic resonance spectroskopy (preliminary report)

Ficek K, Tarnawski R, Miszczyk L, Blamek S.
p. 57-57

Radical radiotherapy of muscle-invading bladder cancer (BC): A retrospective analysis of 49 patients

Zaucha R, Kobierska A, Nowaczyk M, Zaborowska J, Jassem J.
p. 57-58

Zastosowanie pamidronianu u chorych z przerzutami raka do kości

Gisterek I, Winkler-Spytkowska B, Maciejczyk A.
p. 58-58

Variants of preoperative thermoradiotherapy in locally advanced breast cancer patients

Trofimova O, Tkachev SI, Ivanov VM.
p. 58-59

Meningiomas treated in Greatpoland Cancer Center between 1990-1997

Mróz-Bąk G, O'Shea A, Jezierska D, Kubaszewska M.
p. 59-59

The results of postoperative radiotherapy in 63 patients with low-grade gliomas treated in Greatpoland Cancer Center

Mróz-Bąk G, Dymnicka M, Piotrowski T, Kubaszewska M.
p. 59-59

Cancer of oropharynx and nasopharynx - clinical prognoestic factors analysis

Syguła M, Pilecki B, Sąsiadek W, Goleń M, Przeorek W, Wygoda A, Składowski K.
p. 60-60

Concurrent weekly cisplatin and radiotherapy in cervical cancer patients. A report on acute toxicity

Serkies K, Krasinska L, Sawicki T, Jassem J.
p. 60-60

The rational for optimal combination of radiation therapy and taxanes in organ preservation treatment of head and neck cancer - project of clinical study

Rutkowski T, Sąsiadek W, Mucha A, Składowski K.
p. 60-60

Validity of accelerated hyperfractionated conformal radiation therapy and monitoring of treatment results in patients with advanced NSCLC. Assessment of tolerance and early failure

Jochymek B, Dybek M, Radkowski A, Gawlikowicz M.
p. 61-62

Retrospektywna ocena wczesnych i późnych odczynów popromiennych w śluzówkach jamy ustnej po pooperacyjnym napromienianiu z powodu raka przyusznicy

Laskus Z.
p. 61-62

Ocena wczesnej toksyczności skojarzonej radiochemioterapii miejscowo zaawansowanego raka szyjki macicy

Wieczorek A, Kędzierawski P, Smok- Kalwat J, Banatkiewicz P.
p. 62-62

Screening for prostate cancer in Greatpoland Cancer Center

O'Shea A, Mróz Bąk G, Kubaszewska M, Nowakowska E, Skowronek J, Adamska K.
p. 63-63

The effectiveness of pain treatment with Strontium 89 in patient with osseous metastases

Nowakowska E, Milecki P, Sibilska E, Kubicka M, Bąk G, Skowronek J, O' Shea A, Adamska K.
p. 63-63

Radiation treatment of painful vertebral hemangiomas

Miszczyk L, Ficek K, Trela K, Spindel J.
p. 63-64

Radiotherapy for painful scalupo-humeral periarthritis

Miszczyk L, Woźniak G, Walichiewicz P, Spindel J.
p. 64-64

IBU and CT based conformal hdr brachytherapy

Bystrzycka J, Ślosarek K, Białas B, Rembielak A.
p. 64-64

Astrocytoma u chorego z wieloletnim przebiegiem białaczki włochatokomórkowej

Ceglarek B, Sikorska A, Konopka L.
p. 64-64

Objawy uszkodzenia centralnego układu nerwowego, będące maską rozpoznania sarcoma granulocytium

Sikorska A, Ceglarek B, Konopka L.
p. 65-65

Dozymetryczna weryfikacja metod korekcji niejednorodności w systemie planowania leczenia CADPLAN

Laskosz I, Janiszewska M, Nowakowski G, Kulaszewski K.
p. 66-66

Technika łączenia obrazów w planowaniu leczenia pacjentów chorych na nowotwór pęcherza

Wieczorek A, Kuszewski T, Selerski B, Kędzierawski P.
p. 66-67

High dose rate endobronchial brachytherapy in the management of advanced bronchial cancer - comparison of different doses

Skowronek J, Adamska K, Zwierzchowski G, Cofta S, Świerkocki K, Piorunek T, Młynarczyk W.
p. 67-67

Comparison results of different strategies of radiotherapy in nasopharyngeal carcinoma

Fundowicz D, Kruk-Zagajewska A, Adamiak E, Matecka-Nowak M, Milecki P, Stryczyńska G.
p. 67-68

Results of the breast conserving therapy in early breast cancer

Adamiak E, Fundowicz D, Matecka-Nowak M, Milecki P, Stryczyńska G.
p. 68-68

Ocena wiarygodności biopsji węzła wartowniczego (ww) w czerniaku złośliwym skóry (I stopień zaawansowania klinicznego)

Murawa P, Gracz A, Mańczak M, Nowakowski W, Wasiewicz J, Malicki J.
p. 68-69

Early toxicity in 3 D CRT of lung cancer

Matecka-Nowaka M, Fundowicz D, Adamiak E, Milecki P, Stryczyńska G.
p. 69-69

Medulloblastoma in material of Greatpoland Cancer Center between 1990 and 1997

Mróz-Bąk G, Jezierska D, Nowakowska E, Kubaszewska M.
p. 69-69

« back


Indexed in: EMBASE®, the Excerpta Medica database, the Elsevier BIOBASE (Current Awareness in Biological Sciences) and in the Index Copernicus.